Epilepsia Publishes Results From Two Studies Of Eisai's Perampanel
09:37 EDT 20 Aug 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
WOODCLIFF LAKE, N.J., Aug. 20, 2012 /PRNewswire/ -- Eisai Inc. announced today that the results of two studies: "Evaluation of Adjunctive Perampanel in Patients with Refractory Partial Onset Seizures: Results of Randomized Global Phase III Study 305," and ...
Other Sources for this Article
More From BioPortfolio on "Epilepsia Publishes Results From Two Studies Of Eisai's Perampanel"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
